Advances in anticancer radiopharmaceuticals. by Jackson, MR, Falzone, N, Vallis, K

EGF-coated gold nanoparticles provide an efficient nano-scale delivery system for the molecular radiotherapy of EGFR-positive cancer. by Song, L, Falzone, N, Vallis, K

PET imaging of DNA damage using 89Zr-labelled anti-γH2AX-TAT immunoconjugates by Knight, J, Topping, C, Mosley, M, Kersemans, V, Falzone, N, Falzone, N, Fernández-Varea, J, Cornelissen, B

Targeted radionuclide therapy: new advances for improvement of patient management and response by Malcolm, J, Falzone, N, Lee, B, Vallis, K

Targeted radionuclide therapy in combined-modality regimens by Gill, M, Falzone, N, Du, Y, Vallis, K

Combining external beam radiation and radionuclide therapies: rationale, radiobiology, results, and roadblocks by Abbott, E, Falzone, N, Lenzo, N, Vallis, K

SPECT imaging and biodistribution studies of 111In-EGF-Au-PEG nanoparticles in vivo by Song, L, Able, S, Falzone, N, Kersemans, V, Vallis, K

Internalization of Auger electron-emitting isotopes into cancer cells: A method for spatial distribution determination of equivalent source terms by Vallis, K, Royle, G, Falzone, N, Chakalova, R, Myhra, S

Subcellular targeting of theranostic radionuclides by Bavelaar, B, Lee, B, Gill, M, Falzone, N, Vallis, K

Chemically amplified photoresist for high resolution autoradiography in targeted radiotherapy. by Falzone, N, Nathan, R, Myhra, S, Chakalova, R, Altebaeumer, T, Vallis, K

Photoresists as a high spatial resolution autoradiography substrate for quantitative mapping of intra- and sub-cellular distribution of Auger electron emitting radionuclides. by Falzone, N, Myhra, S, Chakalova, R, Royle, G, Altebaeumer, T, Nathan, R, Vallis, K

Targeting micrometastases: The effect of heterogeneous radionuclide distribution on tumor control probability by Falzone, N, Lee, B, Able, S, Malcolm, J, Terry, S, Alayed, Y, Vallis, K

Single cell S-value calculations of a stochastic cascade model for Auger-electron emitting radionuclides by Vallis, K, Falzone, N, Lee, B, Fernandez-Varea, J, Kibedi, T, Stuchbery, A

MRI imaging for sensitive tumour cell-tracking during development of early brain metastasis in a preclinical model by Corroyer-Dulmont, A, Valable, S, Falzone, N, Sibson, NR, Bernaudin, M, Vallis, KA

Targeted alpha therapy with 212Pb or 225Ac: Change in RBE from daughter migration by Ackerman, N, De La Fuente Rosales, L, Falzone, N, Vallis, K, Bernal, M

Absorbed dose evaluation of auger electron-emitting radionuclides: impact of input decay spectra on dose point kernels and S-values by Falzone, N, Lee, B, Fernández-Varea, J, Kartsonaki, C, Stuchbery, A, Kibedi, T, Vallis, K

Amplification of DNA damage by a γH2AX-targeted radiopharmaceutical by Cornelissen, B, Darbar, S, Kersemans, V, Allen, D, Falzone, N, Barbeau, J, Smart, S, Vallis, K

Stereotactic inverse dose planning following yttrium-90 selective internal radiotherapy in hepatocellular cancer by Abbott, EM, Young, R, Hale, C, MItchell, K, Falzone, N, Vallis, K, Kennedy, A

Amplification of DNA damage by a γH2AX-targeted radiopharmaceutical. by Cornelissen, B, Darbar, S, Kersemans, V, Allen, D, Falzone, N, Barbeau, J, Smart, S, Vallis, K

I131-MIBG treatment revisited: How important is scheduling when combined with external beam irradiation? by Corroyer-Dulmont, A, Falzone, N, Able, S, Kersemans, V, Thompson, J, Allen, D, Smart, S, Vallis, K